Skip to content

Molecular Characterization of Carbapenemase-Producing Enterobacterales

Molecular Characterization of Carbapenemase-Producing Enterobacterales Isolated From Clinical Samples in Egypt

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07116356
Enrollment
100
Registered
2025-08-11
Start date
2025-09-10
Completion date
2026-02-20
Last updated
2025-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myeloid Leukemia

Keywords

Carbapenem, enterobacterials,, Antibitic sensitivity, PCR

Brief summary

Bacterial infections with carbapenem resistant pathogens are one of the major threats in immunocompromised patients, especially among cancer patients .Furthermore, Gram negative pathogens are becoming increasingly prevalent and have become an ongoing global health concern .Emergence of Gram-negative pathogens, especially Enterobacterales that avert many of the human defense mechanisms are alarmingly increasing and most of these pathogens are resistant to many of the in-use antibiotics including carbapenems .

Interventions

different samples were collected from patients admitted at oncology center at sohag

Molecular detection of carbapenem resistant genes: * Extraction of nucleic acid from isolated organisms by boiling. * Primers will be used for detection of carbaenem resistant genes

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SCREENING
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
4 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* All patients admitted to Sohag Oncology Center have different infections and isolated organism one of carbapenem resistant enterobacterales detected by antibiotic sensitivity test.

Exclusion criteria

* All patients admitted to Sohag Oncology Center having infections in different sites and isolated organisms are not one of enterobacterales and not carbapenem resistant.

Design outcomes

Primary

MeasureTime frame
Isolation of causative organism6 months

Secondary

MeasureTime frame
Antibitic sensitivity test:2 months
Molecular detection of carbapenem resistant genes:3 months

Countries

Egypt

Contacts

Primary ContactNoha Saber Shafik, Assistant professor
nohasaber@med.sohag.edu.eg+201067261504

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026